Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Biocides; animal or insect repellents or attractants
Reexamination Certificate
1996-05-09
2002-07-09
Levy, Neil S. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Biocides; animal or insect repellents or attractants
C424S409000, C424S421000, C424S423000, C424S602000, C424S403000, C424S404000, C424S406000, C523S218000, C523S219000, C106S690000
Reexamination Certificate
active
06416774
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to particles comprising silica-based, calcium and phosphate containing, glass compositions, and their transformation to calcium-phosphate shells in vitro.
BACKGROUND OF THE INVENTION
In U.S. Pat. No. 5,204,106, issued to Schepers et al., (hereby incorporated by reference) the implantation of bioactive glass granules having the composition: 45% SiO2, 24.5% Na
2
O, 24.5% CaO and 6% P
2
O
5
, and a size range of 280-425 &mgr;m in diameter into the jaw of beagle dogs is disclosed. With particles of this size range, internal pouches formed in each of the particles and, subsequently, osteoprogenitor cells differentiated to osteoblasts within the pouches, actively laying down bone tissue. Next, bone tissue proliferated from the excavations, surrounded the particles and connected with bone tissue being formed around neighboring particles. Bone tissue was formed within the particle, without being bridged to the lingual or buccal bone plates. At 3 months, bone had grown throughout the surgical defects treated with glass granules. A similar phenomenon was not observed with particles of a larger size range, i.e., 480-800 micrometers, or a smaller size range, i.e., 210-300 micrometers.
Glass granules of narrow size range (300-360 &mgr;m) were used in a clinical trial in humans. Schepers et al., “Bioactive Glass Particles of Narrow Size Range: A New Material for the Repair of Bone Defects,”
Implant Dentistry,
2(3):151-156, 1993, incorporated herein by reference. In this clinical study, 87 patients and 106 maxillo facial defects were treated. At 3 months, the application sites had fully solidified. At six months, no radiological difference between the defect sites and the surrounding bone could be discerned.
It was subsequently discovered that particles in the size range 200-300 micrometers effected the same results if implanted into sites exhibiting a reduced metabolic state, particularly as compared to the maxillo-facial sites. Such sites are found, for example, in the appendicular skeleton, and in certain disease states. U.S. application Ser. No. 08/268,510, hereby incorporated by reference.
The in vivo event which initiates the reactions leading to the formation of bone throughout the defects is an excavation of the particles. The excavation is the result of physico-chemical reactions taking place in the glass, as well as a cell mediated resorption of the internal reaction layer. Bioactive glass reacts at its surface with the formation of two reaction layers: a silica gel below the surface and a calcium phosphate rich layer at the surface. In vivo, pouches of biologically formed calcium phosphate are formed. It is within these pouches that osteoprogenitor cells, which freely float around, undergo differentiation to cells expressing the osteoblastic phenotype. This differentiation does not occur outside these biologically formed calcium phosphate pouches.
Even so, it takes approximately one month for the particles to excavate in vivo. A means for further expediting the healing process would be advantageous.
SUMMARY OF THE INVENTION
The present invention can further expedite the healing process through the excavation of silica-based glass particles in vitro. According to the present invention, silica-based, Ca,P-containing glasses are transformed to hollow CaP-shells in vitro, prior to implantation. The silica-based glass granules can be melt- or sol-gel derived. The resultant hollow shells comprise an outer, nanoporous, carbonated amorphous or crystalline CaP-rich layer, with or without remaining silica.
In one aspect, the invention relates to the hollow particles which have been formed in vitro.
In another aspect, the invention relates to a method for producing the hollow calcium-phosphate particles according to the invention involving a differential immersion of the particles in solutions which provoke the dissolution of the silicon from the particles.
REFERENCES:
patent: 3960583 (1976-06-01), Netting et al.
patent: 4293540 (1981-10-01), Shibita et al.
patent: 4340642 (1982-07-01), Netting et al.
patent: 4411847 (1983-10-01), Netting et al.
patent: 4657810 (1987-04-01), Doyden
patent: 4842863 (1989-06-01), Nishimura et al.
patent: 5002890 (1991-03-01), Morrison
patent: 5024826 (1991-06-01), Linton
patent: 5055307 (1991-10-01), Tjuru et al.
patent: 5204106 (1993-04-01), Schepers et al.
patent: 5328955 (1994-07-01), Rhee et al.
patent: 5356617 (1994-10-01), Shlossman
patent: 5480844 (1996-01-01), Matsui et al.
patent: 5591453 (1997-01-01), Ducheyne et al.
patent: 5593680 (1997-01-01), Bara et al.
patent: WO 00/44681 (2000-08-01), None
Radin, S., et al., “Transformation of bioactive glass granules into CA-P shells in vitro,”Bioceramics, Proceedings of the 10thInternational Symposium on Ceramics in Medicine, Paris, France, Oct. 1997, 10, 45-48, XP-000978406.
Supplementary European Search Report dated Jan. 22, 2001.
Ayyaswamy et al. (Invests.), Executive Summary and Research Project Description of invention, Sep. 1995, 27 pages.
Ducheyne, P., “Bioglass Coatings and Bioglass Composites as Implant Materials”,J. Biomed. Mat. Res., 1985, 19, 273-291.
Ducheyne, P., “The Use of Bioactive Glass Particles as Microcarriers in Microgravity Evironment”,Microgravity Science&Applications: Program Tasks and Bibliography for FY 1995, NASA Technical Memorandum 4735, 1996.
Heinoken et al., “A New and Convenient Colorimetric Determination of Inorganic Orthophosphate and its Application to the Assay of Inorganic Pyrophosphate”,Anal. Biochem., 1981, 113, 313-317.
O'Connor et al., “The Kinetics for the Solution of Silica in Aqueous Solutions”,J. Phys. Chem., 1958, 62, 1195-1198.
Schepers et al., “Bioactive Glass Particles of Narrow Size Range: A new Material for the Repair of Bone Defects”,Implant Dentistry, 1993, 2(3), 151-156.
Ishii et al JP 07157439 Hcaplus Abstract #1995:773247, Jun. 1995.*
NGK -JP 59101145 WPI05 Abstract #84-180011(29), Jun. 1984.*
Mitsubishi -JP 60106459 HCaplus 1985:583602, Jun. 1985.*
Sugama et al: Chem. Conct. Res. 25(6) pp. 1305-1310 1995.*
Drenert: DE 4222763, Jan. 1994.*
Yoshiko et al JP 62-158485, Jul. 1987.*
Paul et al J. Mat. Sci. Lett. 14(24) pp. 1792-1794, 1995.
Ayyaswamy Portonovo S.
Ducheyne Paul
Falaize Sylvie
Radin Shulamith
The Trustees of the University of Pennsyvania
Woodcock & Washburn LLP
LandOfFree
Hollow bone mineral-like calcium phosphate particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hollow bone mineral-like calcium phosphate particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hollow bone mineral-like calcium phosphate particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2889104